Clinical Trial Update: Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating semaglutide for non-alcoholic steatohepatitis (NASH); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Non-alcoholic Steatohepatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING